Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1.
about
cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injuryRenal endothelial dysfunction in acute kidney ischemia reperfusion injuryThe renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model.Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools.Cyclic nucleotide signalling in kidney fibrosis.Catalpol protects mice against renal ischemia/reperfusion injury via suppressing PI3K/Akt-eNOS signaling and inflammation.The protective effect of tadalafil on IMA (ischemia modified albumin) levels in experimental renal ischemia-reperfusion injury.Renoprotective approaches and strategies in acute kidney injuryPhosphodiesterase type 5 inhibitors and kidney disease.Differences in acute kidney injury ascertainment for clinical and preclinical studies.Novel biomarkers for contrast-induced acute kidney injury.Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.Phosphodiesterase-5 inhibitors: emerging nephroprotective drugs.Diabetes increases the susceptibility to acute kidney injury after myocardial infarction through augmented activation of renal Toll-like receptors in rats.
P2860
Q24596767-BAB7D087-E419-468F-A79C-C9EB49501E3EQ26859947-84F91B0E-4E96-4488-BADC-B2A190841E9CQ33863135-9E7A10CD-43F6-4C0A-A1DC-9704C4005089Q34105263-81858FFC-3C68-4F83-800C-E7346955DDC2Q35138860-8FB55F93-45A4-4DFF-8782-5997A95AC0F6Q35479838-EB95B144-8A8A-4878-A585-335F6DA830FCQ36317671-C1D240DE-2112-48ED-8DBD-D46B784E0C08Q37441818-7AD9D776-8349-45EE-80EC-A60911934F7FQ38560737-70BA843F-D155-46C2-956A-2460A70997D7Q39216951-5FAD468A-C595-45D3-B211-80F181563987Q40724654-D133B1B9-4101-4098-AF2A-F70305FD76F3Q41733923-1DF651A9-E346-41DF-8538-1586A28C7A35Q42233587-B2E73927-F1CB-47BD-B27F-30A2F1C55460Q42318493-2A1AB4D6-C355-4C98-8016-D1800E353D1FQ47931207-AE7E01E5-6C23-4ACF-A1D0-F6C14C38E70A
P2860
Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Phosphodiesterase-5 inhibition ...... ent of urinary NGAL and KIM-1.
@en
Phosphodiesterase-5 inhibition ...... ent of urinary NGAL and KIM-1.
@nl
type
label
Phosphodiesterase-5 inhibition ...... ent of urinary NGAL and KIM-1.
@en
Phosphodiesterase-5 inhibition ...... ent of urinary NGAL and KIM-1.
@nl
prefLabel
Phosphodiesterase-5 inhibition ...... ent of urinary NGAL and KIM-1.
@en
Phosphodiesterase-5 inhibition ...... ent of urinary NGAL and KIM-1.
@nl
P2093
P2860
P1476
Phosphodiesterase-5 inhibition ...... ent of urinary NGAL and KIM-1.
@en
P2093
Abeer Abbasi
Bishara Bishara
Doron Aronson
Igor Sukhotnik
Ofer Nativ
Omri Nativ
Rima Sohotnik
Samuel N Heyman
Victor Frajewicki
P2860
P304
P356
10.1152/AJPRENAL.00649.2012
P577
2013-01-30T00:00:00Z